This image compares the studies included in this article with the meta‐analysis from the Cochrane Library, indicating that the incorporation of brachytherapy in neoadjuvant treatment for rectal cancer can achieve better pathological response rates. Additionally, the use of brachytherapy can reduce the local recurrence rate in patients.
Tianyao Wang+6 more
wiley +1 more source
Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma [PDF]
T Noguchi+6 more
openalex +1 more source
Bone Marrow Sparing Intensity Modulated Radiation Therapy is a feasible option for cervical cancer patients treated with extended‐field radiation therapy, it may reduce hematologic toxicity and ensure the continuity of concurrent chemoradiotherapy. Abstract Objective This study aimed to assess the dosimetric parameters and hematological toxicity (HT ...
Jia‐nan Wang+10 more
wiley +1 more source
Complete response of a highly advanced gastric carcinoma to preoperative chemoradiotherapy with S-1 and low-dose cisplatin [PDF]
Nobunari Yoshimizu+8 more
openalex +1 more source
Impact of extending the original criteria in the Chemoradiotherapy for Oesophageal Cancer followed by Surgery Study (CROSS) regimen on treatment outcome in locally advanced esophageal cancer patients. [PDF]
Wang HH+7 more
europepmc +1 more source
Defining a positive circumferential resection margin in oesophageal cancer and its implications for adjuvant treatment [PDF]
Adam+33 more
core +1 more source
Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pilot study [PDF]
Chauhan, Namrata S+4 more
core +1 more source
ABSTRACT Glioblastoma is the most aggressive primary brain tumor, with a median survival of 15 months with treatment. Standard‐of‐care (SOC) consists of resection, radio‐ and chemotherapy. Clinical trials involving PD‐1 inhibition with nivolumab combined with SOC failed to increase survival.
Blanche Mongeon, Morgan Craig
wiley +1 more source
Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma [PDF]
Thomas W. Rice+6 more
openalex +1 more source